NCT06117982View on ClinicalTrials.gov

The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
Primary Ovarian InsufficiencyPremature Ovarian Failure
Interventions
DRUG

Neupogen

Subcutaneous injection of 0.5 ml of Neupogen at a concentration of 300 micrograms/day for 4 consecutive days

Trial Locations (1)

M5G 2K4

Trio Fertility, Toronto

All Listed Sponsors
lead

Trio Fertility

OTHER

NCT06117982 - The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency | Biotech Hunter | Biotech Hunter